Immunic, Inc. (IMUX)
16.50
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
16.50
0.00 (0.00%)
After-Hours: 20:00
Immunic Total Liabilities (Quarterly) : 31.59M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.59M |
| March 31, 2026 | 38.51M |
| December 31, 2025 | 30.72M |
| September 30, 2025 | 30.20M |
| June 30, 2025 | 27.52M |
| March 31, 2025 | 25.80M |
| December 31, 2024 | 22.44M |
| September 30, 2024 | 23.54M |
| June 30, 2024 | 22.92M |
| March 31, 2024 | 20.58M |
| December 31, 2023 | 25.37M |
| September 30, 2023 | 18.57M |
| June 30, 2023 | 19.46M |
| March 31, 2023 | 17.65M |
| December 31, 2022 | 14.07M |
| September 30, 2022 | 12.27M |
| June 30, 2022 | 10.81M |
| March 31, 2022 | 11.96M |
| December 31, 2021 | 11.98M |
| September 30, 2021 | 11.29M |
| June 30, 2021 | 15.32M |
| March 31, 2021 | 17.28M |
| December 31, 2020 | 9.076M |
| September 30, 2020 | 8.765M |
| June 30, 2020 | 8.467M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.804M |
| December 31, 2019 | 7.592M |
| September 30, 2019 | 7.077M |
| June 30, 2019 | 3.163M |
| March 31, 2019 | 1.433M |
| December 31, 2018 | 39.11M |
| September 30, 2018 | 5.736M |
| June 30, 2018 | 8.348M |
| March 31, 2018 | 9.713M |
| December 31, 2017 | 10.34M |
| September 30, 2017 | 8.28M |
| June 30, 2017 | 7.338M |
| March 31, 2017 | 6.519M |
| December 31, 2016 | 5.58M |
| September 30, 2016 | 4.713M |
| June 30, 2016 | 4.485M |
| March 31, 2016 | 4.872M |
| December 31, 2015 | 6.756M |
| September 30, 2015 | 8.265M |
| June 30, 2015 | 10.14M |
| March 31, 2015 | 11.15M |
| December 31, 2014 | 10.52M |
| September 30, 2014 | 8.781M |
| June 30, 2014 | 7.853M |
| March 31, 2014 | 8.912M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Sionna Therapeutics, Inc. | 17.47M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.17M |
| Shareholders Equity (Quarterly) | 127.58M |
| Debt to Equity Ratio | 0.0044 |
| Current Ratio | 5.049 |
| Net Debt Paydown Yield | 0.04% |